Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Daily Tadalafil Therapy on Endothelin-1 and E-Selectin in Diabetic Patients With Erectile Dysfunction

NCT06962462 is registered in ClinicalTrials.gov with South Valley University as lead sponsor.

NCT NCT06962462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06962462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Daily Tadalafil Therapy on Endothelin-1 and E-Selectin in Diabetic Patients With Erectile Dysfunction
Lead sponsor
South Valley University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 5, 2025
Completion date
August 30, 2025
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction associated with type 2 diabetes mellitus